LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312874 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tuuli-Maria Sonninen und 5 weiteren Autor:innen. Beteiligte Einrichtung: A.I. Virtanen Institute, University of Eastern Finland, 70211 Kuopio, Finland. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, alpha-Synuclein, Induced Pluripotent Stem Cells, Endothelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sigrid Juselius Foundation, Doctoral Programme for Molecular Medicine, Finnish Cultural Foundation.
Abstract (Originalsprache)
The blood–brain barrier (BBB) serves as an interface between the bloodstream and the central nervous system. It limits the movement of molecules and immune cells, regulates the entry of nutrients, and removes waste products from the brain. The dysfunction of the BBB has been identified in Parkinson’s disease (PD) but the role of the BBB and endothelial cells (ECs) has not been well studied. LRRK2 G2019S mutation is the most common PD causing mutation with similar pathophysiology than in sporadic cases. How the mutation affects EC function has not been investigated previously in patient cells. In the study, we used iPSC-derived ECs from PD patients with the LRRK2 mutation as well as cells from healthy individuals. We report that PD patients’ ECs have higher levels of α-synuclein and an decreased maximal and ATP-linked respiration and altered response to inflammatory exposure, especially to TNFα. In addition, transcriptomic analysis showed upregulation of fatty-acid-synthesis-related pathways in PD patients’ ECs and the downregulation of lncRNA MEG3, both of which have been associated with PD. Altogether, PD patients’ ECs manifest some of the PD-related hallmarks and are likely to contribute to the pathogenesis of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- A.I. Virtanen Institute, University of Eastern Finland, 70211 Kuopio, Finland.
- Helsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.
- Drug Research Program, Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014 Helsinki, Finland.
- Neuroscience Center, University of Helsinki, 00014 Helsinki, Finland.
ORCID-Profile: Tuuli-Maria Sonninen, Jonna Niskanen, Riikka H Hämäläinen, Šárka Lehtonen
Förderung
- Sigrid Juselius Foundation
- Doctoral Programme for Molecular Medicine
- Finnish Cultural Foundation
- Business Finland
Zitieren
APA
Sonninen, T. M., Peltonen, S., Niskanen, J., Hämäläinen, R. H., Koistinaho, J., & Lehtonen, Š. (2024). LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312874
Vancouver
Sonninen TM, Peltonen S, Niskanen J, Hämäläinen RH, Koistinaho J, Lehtonen Š. LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312874
BibTeX
@article{Sonninen2024,
author = {Sonninen, Tuuli-Maria and Peltonen, Sanni and Niskanen, Jonna and Hämäläinen, Riikka H and Koistinaho, Jari and Lehtonen, Šárka},
title = {LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312874}
}
EUVIMED